ADD_Program
@addprogram
The Anticonvulsant Drug Development (ADD) Program is involved in identification and characterization of novel Drugs for Epilepsy and is the ETSP- contract site.
ID: 1149356968265433088
https://pharmacy.utah.edu/add/ 11-07-2019 16:37:10
789 Tweet
287 Followers
443 Following
Our Theiler's Murine Encephalomyelitis Virus (TMEV) comprehensive pharmacology paper got published recently! pubmed.ncbi.nlm.nih.gov/34668659/ Congratulations to everyone involved with this project Cameron Metcalf @kswilcox Peter J. West